Hangzhou Tigermed Consulting Co., Ltd (SHE:300347)
58.17
+2.33 (4.17%)
Mar 14, 2025, 2:45 PM CST
SHE:300347 Revenue
Hangzhou Tigermed Consulting had revenue of 1.71B CNY in the quarter ending September 30, 2024, a decrease of -11.87%. This brings the company's revenue in the last twelve months to 6.80B, down -7.21% year-over-year. In the year 2023, Hangzhou Tigermed Consulting had annual revenue of 7.38B with 4.21% growth.
Revenue (ttm)
6.80B
Revenue Growth
-7.21%
P/S Ratio
7.40
Revenue / Employee
701.08K
Employees
9,701
Market Cap
46.91B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7.38B | 298.57M | 4.21% |
Jan 1, 2023 | 7.09B | 1.87B | 35.91% |
Jan 1, 2022 | 5.21B | 2.02B | 63.32% |
Dec 31, 2020 | 3.19B | 388.97M | 13.88% |
Dec 31, 2019 | 2.80B | 502.65M | 21.85% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 26.00B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 38.50B |
Aier Eye Hospital Group | 20.62B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Shanghai United Imaging Healthcare | 10.30B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Beijing Wantai Biological Pharmacy Enterprise | 2.49B |
Hangzhou Tigermed Consulting News
- 7 months ago - Hangzhou Tigermed Consulting reports Q2 results - Seeking Alpha